Norcantharidin suppresses cell growth and migration with enhanced anticancer activity of gefitinib and cisplatin in human non-small cell lung cancer cells-Reference-Cited by-同舟云学术

Norcantharidin suppresses cell growth and migration with enhanced anticancer activity of gefitinib and cisplatin in human non-small cell lung cancer cells

Published:2012-10-31 Issue:1 Volume:29 Page:237-243
ISSN:1021-335X
Container-title:Oncology Reports
language:en
Short-container-title:

Author:

LEE YA-CHUN,LEE LIANG-MING,YANG CHIH-HSIN,LIN ANYA MAAN-YUH,HUANG YI-CHIA,HSU CHIA-CHI,CHEN MENG-SHIAN,CHI CHIN-WEN,YIN PEN-HUI,KUO CHENG-DENG,LIAO JYH-FEI,LEE HSIN-CHEN

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Norcantharidin Sensitizes Lung Adenocarcinoma Cells to Multitherapy via Targeting the Deregulated Hedgehog Cascade;2024-08-20

2. Norcantharidin in cancer therapy – a new approach to overcoming therapeutic resistance: A review;Medicine;2024-03-01

3. Self-Assembly of a Linear–Dendritic Polymer Containing Cisplatin and Norcantharidin into Raspberry-like Multimicelle Clusters for the Efficient Chemotherapy of Liver Cancer;ACS Applied Materials & Interfaces;2023-03-07

4. Fabrication of epidermal growth factor imprinted and demethylcantharidin loaded dendritic mesoporous silica nanoparticle: An integrated drug vehicle for chemo-/antibody synergistic cancer therapy;Journal of Drug Delivery Science and Technology;2021-04

5. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010–2020);European Journal of Medicinal Chemistry;2020-12